Factors influencing ovarian cancer survival after chemotherapy
Webb, M.J.; Malkasian, G.D.; Jorgensen, E.O.
Obstetrics and Gynecology 44(4): 564-570
1974
ISSN/ISBN: 0029-7844 PMID: 4413425 Document Number: 72362
Document emailed within 1 workday
Related Documents
Webb, M.J.; Decker, D.G.; Mussey, E. 1975: Cancer metastatic to the ovary: factors influencing survival Obstetrics and Gynecology 45(4): 391-396Koyama, Y.; Kurita, H.; Koike, T.; Kamata, T.; Nakanishi, Y.; Kobayashi, H. 2014: Retrospective analysis of clinical and pathological factors that influence patient survival in salivary gland cancer - could chemotherapy improve survival ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(2): 199-204
Brightwell, R.; Eng, K.; Lele, S. 2017: Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients European Journal of Gynaecological Oncology 38(3): 378-381
Venesmaa, P. 1994: Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstetrics and Gynecology 84(1): 8-11
Kawabata, R.; Imamura, H.; Kishimoto, T.; Hachino, Y.; Yasui, Y.; Fujino, M.; Fujii, C.; Fukunaga, M.; Ohzato, H.; Furukawa, H. 2012: Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1205-1208
Sellner, F.; Dinges, H.P.; Jelinek, R. 1982: Factors influencing the survival time of patients subjected to "radical" surgery for cancer of the papilla of Vater Wiener Klinische Wochenschrift 94(1): 5-9
Herr, H.W.; Klein, E.A.; Rogatko, A. 1991: Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival European Urology 19(2): 97-100
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Bliumenberg, A.G.; Gorbacheva, L.B.; Gorbunova, V.A.; Kozachenko, V.P.; Lankin, V.Z. 1996: Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives Biulleten' Eksperimental'noi Biologii i Meditsiny 122(12): 651-654
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Takashi, M.; Murase, T.; Aota, Y.; Nagai, T.; Kinjo, T.; Sabashi, M.; Shimoji, T.; Miyake, K.; Hamajma, N.; Mizuno, S. 1988: Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy Hinyokika Kiyo. Acta Urologica Japonica 34(8): 1377-1381
Crvenkova, S.; Pesevska, M. 2015: Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy Journal of Buon: Official Journal of the Balkan Union of Oncology 20(3): 775-781
Chablani, U.A.; Mehta, M.M.; Contractor, N.M.; Bhatia, H.M. 1988: HLA & other factors influencing survival of transplanted kidney Indian Journal of Medical Research 88: 235-239
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Van Rood, J.J.; Persijn, G.G.; Paul, L.C.; Cohen, B.; Lansbergen, Q.; Goulmy, E.; Claas, F.H.; Baldwin, W.; van Es, L.A. 1981: Significant factors influencing kidney graft survival Transplantation Proceedings 13(1 Part 2): 909-912
Jonasson, O.; Moses, V. 1981: Factors influencing first cadaver renal allograft survival Transplantation Proceedings 13(1 Part 1): 44-47
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Zhang, J.-T.; Wang, L.; Wu, Z.; Jia, G.-J.; Zhang, L.-W. 2007: Factors influencing the survival of patients with skull base chordoma Zhonghua Yi Xue Za Zhi 87(23): 1607-1610
Vekemans, M. 1989: An investigation of factors influencing the survival of trisomic fetuses in the mouse Progress in Clinical and Biological Research 311: 245-262